BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35235020)

  • 1. Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis.
    De Virgilio A; Costantino A; Festa BM; Mercante G; Franceschini D; Franzese C; Scorsetti M; Marrari A; Cavina R; Marano S; Castoro C; Spriano G
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1029-1041. PubMed ID: 35235020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reply to Letter to the Editor regarding "Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis".
    De Virgilio A; Costantino A; Festa BM; Mercante G; Franceschini D; Franzese C; Scorsetti M; Marrari A; Cavina R; Marano S; Castoro C; Spriano G
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1369-1371. PubMed ID: 36309603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
    Wang J; Wu Y; Zhang W; Chen Y; Liu Q; Jing S; Zhang J; Wu F; Wang J; Qiao X
    Radiat Oncol; 2023 Aug; 18(1):142. PubMed ID: 37641149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
    de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
    Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al.
    Guler OC; Onal C
    J Cancer Res Clin Oncol; 2022 Sep; 148(9):2567-2568. PubMed ID: 35697858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study.
    Li HX; Liu J; Cheng Y; Liu MN; Fang WT; Lv CX
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29294022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
    Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
    Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Definitive Chemoradiotherapy for Cervical and Upper Thoracic Esophageal Cancers: a Single-Institution Experience of a Rare Cancer.
    Esmati E; Maddah Safaei A; Ghalehtaki R; Mousavi N; Saraee E; Shirouei S; Mohammadi N; Lashkari M
    J Gastrointest Cancer; 2019 Sep; 50(3):380-385. PubMed ID: 29497928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do higher radiation doses improve survival for cervical esophageal squamous cell cancer patients treated with definitive chemoradiotherapy using intensity-modulated radiotherapy? A propensity-score matched analysis.
    Xie F; Liu T; Wang X; Dong J; Huang W; Sun H
    J Cancer Res Ther; 2023 Dec; 19(6):1582-1588. PubMed ID: 38156925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma.
    Ochi M; Murakami Y; Nishibuchi I; Kubo K; Imano N; Takeuchi Y; Kimura T; Hamai Y; Emi M; Okada M; Nagata Y
    J Radiat Res; 2021 Jan; 62(1):142-148. PubMed ID: 33392619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.
    Zhang T; Guo Z; Chen X; Dong J; Jiang H; Tang P; Wang P; Qian D; Zhang W; Pang Q
    Radiat Oncol; 2022 Aug; 17(1):148. PubMed ID: 35999608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcomes of cervical esophageal cancer treated primarily with surgery: a systematic review and meta-analysis.
    De Virgilio A; Costantino A; Festa BM; Mercante G; Franceschini D; Franzese C; Scorsetti M; Marrari A; Cavina R; Marano S; Castoro C; Spriano G
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):373-390. PubMed ID: 35969248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Treatment Outcomes of the Elder Patients with Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy or Radiotherapy.
    Liu J; Li Y; Chen Y; Jiang X; Yu H; Yan S
    Contrast Media Mol Imaging; 2022; 2022():3678441. PubMed ID: 35924070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Hatogai K; Yano T; Kojima T; Onozawa M; Daiko H; Nomura S; Yoda Y; Doi T; Kaneko K; Ohtsu A
    Gastrointest Endosc; 2016 Jun; 83(6):1130-1139.e3. PubMed ID: 26608125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
    Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
    J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis.
    Luo HS; Huang HC; Lin LX
    Radiat Oncol; 2019 Oct; 14(1):178. PubMed ID: 31623639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
    Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
    Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.